Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,819,200
-$6,033,989 QoQ
Shares Held
340,000
-61.2% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#37
of 218 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Derivatives in LEGN
reported options exposure · as of Mar 31, 2026CallValue
$2,717,118
CallShares
150,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. LEGN ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,440 | $193,943,261 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
825,002 | $47,206,614 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,720 | $44,769,181 | |
| 4 | BNTX |
BioNTech SE
|
260,000 | $24,193,000 | |
| 5 | IMCR |
Immunocore Holdings plc
|
590,000 | $18,732,500 | |
| 6 | TECH |
BIO-TECHNE Corp
|
200,000 | $14,130,000 | |
| 7 | VIR |
Vir Biotechnology, Inc.
|
1,364,000 | $13,899,160 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
159,778 | $13,033,091 |
All Filings in LEGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,819,200 | 340,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,853,189 | 876,351 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $2,717,118 | 150,200 | Call | Sole | 2026-05-13 | |
| 2025-12-31 | $12,500,500 | 575,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,174,200 | 220,000 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $5,483,205 | 154,500 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $5,937,750 | 175,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,589,350 | 202,500 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $2,435,950 | 55,000 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $3,008,500 | 50,000 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $1,938,000 | 47,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $69,236,750 | 1,258,850 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $46,564,259 | 1,281,350 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $87,456,673 | 1,876,350 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $94,987,476 | 1,878,708 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $77,107,252 | 1,878,374 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $62,894,291 | 2,167,274 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $77,023,400 | 2,735,206 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $87,232,631 | 2,825,806 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $130,077,915 | 3,056,342 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||